JD Davids is the former senior editor and the director of strategic communications at TheBody.com and TheBodyPRO.com. He joined our editorial team in 2014 and left in 2018.
A longtime HIV/AIDS activist and communication strategist, JD has had the privilege of organizing people living with HIV and people in the LGBTQ community, as well as those who love them, to stand up for their rights, access lifesaving information, slash the global price of HIV treatment, expand syringe access, win a national HIV strategy for the United States, confront the crisis in prison medical care, and demand HIV prevention tools that actually make sex better.
Along the way, he's collected acronyms as a co-founder of Project TEACH at Philadelphia FIGHT, community organizer at Health GAP, director of mobilization at AIDS Foundation of Chicago, member of ACT UP Philadelphia, and devoted ally of the Positive Women's Network - USA. JD also founded Community HIV/AIDS Mobilization Project (CHAMP) and the HIV Prevention Justice Alliance (HIV PJA)
Additionally, JD has served as an advisor to the U.S. National Institutes of Health and Centers for Disease Control and Prevention, among many other projects and organizations.
Now living in Brooklyn, N.Y., he parents a kid, cat and snake, and is a member of both the Aftselakhis Spectacle Committee and Jews for Racial and Economic Justice.
Follow JD on Twitter: @JDAtTheBody.
Within the past year, JD Davids has had some form of official relationship with each of the following groups/organizations that have a stake in the fight against HIV. These disclosures were last updated on April 19, 2017.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Post-AIDS 2018 Updates on HIV Cure Research|
|Video SNiP: PET Scan "Hot Spots" Help Visualize Inflammatory Complication of HIV|
|This Week in HIV Research: Many Black MSM on PrEP Are Already Positive|
|HIV-Negative Black Gay Men: Two Recent Studies Show Some Factors That Help Them to Remain So|
|What's Really Behind the Recent Decline in U.S. Hepatitis C Prevalence?|